NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-349 Cr | ₹169 Cr | ₹225 Cr | ₹134 Cr | ₹95 Cr |
What is the latest Cash Flow from Operating Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-349 Cr |
| Mar2025 | ₹169 Cr |
| Mar2024 | ₹225 Cr |
| Mar2023 | ₹134 Cr |
| Mar2022 | ₹95 Cr |
How is Cash Flow from Operating Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-349 Cr | Negative | |
| Mar2025 | ₹169 Cr | -24.59 | |
| Mar2024 | ₹225 Cr | 68.11 | |
| Mar2023 | ₹134 Cr | 40.68 | |
| Mar2022 | ₹95 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹197.2 Cr | -1.4% | -8% | -35% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -1.4% |
-8% |
-35% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses